| Stage | RDNT | % of rev | PTGX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $623M | 100.00% | $213M | 100.00% | RDNT ×2.92 |
| Gross profit | $88M | 14.14% | $213M | 100.00% | PTGX +85.9pp |
| Operating income | $39M | 6.34% | $159M | 74.37% | PTGX +68.0pp |
| Pre-tax income | $27M | 4.27% | $165M | 77.35% | PTGX +73.1pp |
| Net income | $20M | 3.25% | $163M | 76.28% | PTGX +73.0pp |
| Stage | RDNT | PTGX | Gap · A − B |
|---|---|---|---|
| Revenue | $623M100.00% | $213M100.00% | RDNT ×2.92 |
| Gross profit | 14.14%$88M | 100.00%$213M | PTGX +85.9pp |
| Operating income | 6.34%$39M | 74.37%$159M | PTGX +68.0pp |
| Pre-tax income | 4.27%$27M | 77.35%$165M | PTGX +73.1pp |
| Net income |
| 3.25%$20M |
| 76.28%$163M |
| PTGX +73.0pp |
No shared counterparties.